Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
1E Therapeutics logo — Clinical stage drug development company creating novel RNA-t...

1E Therapeutics

Clinical stage drug development company creating novel RNA-targeting drugs

Founded 2020 Israel Israel 50 employees Seed Biotechnology, Health and Wellness

General Information

Company Name 1E Therapeutics
Founded Year 2020
Location Israel Israel
Employees 50
Industries Biotechnology, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with 1E Therapeutics. To contact 1E Therapeutics, visit 1etx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does 1E Therapeutics compare?

A PDF of 1E Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting 1E Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About 1E Therapeutics

1E Therapeutics (1Etx) is a breakthrough drug development company creating first-in-class RNA-targeting therapeutics based on our proprietary drug design platform. 1E is the culmination of years of innovation, effort, and tens of millions of $US investment in research and development. 1E's proprietary and groundbreaking rapid drug design process has proven uniquely able to develop innovative drugs that address chronic life threatening indications as well as emerging and evolving pathogens. 1E already has lead compounds that address a wide array of indications in oncology, age-related diseases, anti-microbial resistance, and neurological disorders.

No funding data available for 1E Therapeutics yet.

FAQ About 1E Therapeutics

Clinical stage drug development company creating novel RNA-targeting drugs
1E Therapeutics was founded in 2020.
1E Therapeutics is headquartered in Israel.
1E Therapeutics operates in Biotechnology and Health and Wellness.
1E Therapeutics has approximately 50 employees.

We're actively collecting intelligence on 1E Therapeutics.

Source: BounceWatch company record for 1E Therapeutics, https://bouncewatch.com/company/1e-therapeutics, updated 7 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes